Evidence map›Paper›PMID 41727426›Full record

ArticleFrontiers in immunology2026

Neutrophils and aortic medial amyloid: mutually beneficial or a dangerous combination?

Alana Maerivoet, Sarah Shirley, Rebecca Price, David Wilkinson, Helen L Wright, Jillian Madine

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alana Maerivoet *Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Sarah Shirley *Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Rebecca PriceInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
David WilkinsonInstitute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.
Helen L WrightInstitute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.
Jillian MadineInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Amyloid deposition and inflammation are associated with many human diseases, with inflammatory cells found co-localised with amyloid in a range of tissues. Medin is the peptide that forms the most common localised amyloid in the aortic medial layer, yet remarkably little is known about its role in disease or factors that modulate its aggregation. Methods: We investigated the effect of neutrophil degranulation supernatants on medin fibril formation Results: We showed that neutrophil supernatants reduced fibril formation of medin and its associated cell toxicity. Addition of inhibitors targeting MMPs (GM6001) and serine proteases (AEBSF) reversed the effects of neutrophils on fibril formation and cell toxicity. In contrast, inhibiting cysteine proteases using E64 showed comparable low ThT fluorescence and a lack of fibrils similar to what is observed for medin in the presence of neutrophil supernatants alone. However, despite appearing comparable to neutrophils alone, species produced showed significantly increased cell toxicity of up to 60% (P<0.0001). Discussion: This data has implications for understanding the role of neutrophil-mediated inflammation in medin-associated pathologies and provides avenues to explore for future therapeutic intervention.

Indexed as

AmyloidAortaNeutrophilsAnimalsCell DegranulationHumansInflammationAmyloidaortic medial amyloidaortic pathologiesinflammationneutrophilprotein aggregation

Identifiers

PMID41727426
PMCPMC12920188

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.